Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Teng

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
BMC Cancer|April 18, 2015
YY1 suppresses FEN1 over-expression and drug resistance in breast cancerJianwei Wang, Lina Zhou, Zhi Li, et al.
The Journal of Infectious Diseases|February 28, 2015
Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV InfectionLouise C Ivers, Richelle C Charles, Isabelle J Hilaire, et al.
Plos Neglected Tropical Diseases|May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in HaitiRichelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
American Heart Journal|December 17, 2025
A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responsesSarah D de Ferranti, Jessica E Teng, Silva A Arslanian, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Journal of Clinical Lipidology|May 6, 2026
A 2-year randomized trial of pitavastatin calcium versus placebo to treat combined dyslipidemia in adolescents with overweight and obesityBrian W McCrindle, Silva Arslanian, Michele Mietus-Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA TrialRuo-Xi Hong, Fei Xu, Wen Xia, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
International Journal of Cancer|July 24, 2020
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological studyZong-Bi Yi, Pei Yu, Su Zhang, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
BMC Cancer|April 18, 2015
YY1 suppresses FEN1 over-expression and drug resistance in breast cancerJianwei Wang, Lina Zhou, Zhi Li, et al.
The Journal of Infectious Diseases|February 28, 2015
Immunogenicity of the Bivalent Oral Cholera Vaccine Shanchol in Haitian Adults With HIV InfectionLouise C Ivers, Richelle C Charles, Isabelle J Hilaire, et al.
Plos Neglected Tropical Diseases|May 3, 2014
Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in HaitiRichelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, et al.
American Heart Journal|December 17, 2025
A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responsesSarah D de Ferranti, Jessica E Teng, Silva A Arslanian, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Journal of Clinical Lipidology|May 6, 2026
A 2-year randomized trial of pitavastatin calcium versus placebo to treat combined dyslipidemia in adolescents with overweight and obesityBrian W McCrindle, Silva Arslanian, Michele Mietus-Snyder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA TrialRuo-Xi Hong, Fei Xu, Wen Xia, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
International Journal of Cancer|July 24, 2020
Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological studyZong-Bi Yi, Pei Yu, Su Zhang, et al.
Pageof 9